AWARENESS OF HERPETIC NEURITIS AMONG DENTAL PRACTITIONERS

Authors

  • Aparna M Undergraduate student, Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India Author
  • Dhanraj Ganapathy Professor &Head of Department, Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India Author
  • Subhashree Rohinikumar Senior Lecturer, Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India Author

DOI:

https://doi.org/10.61841/ychgh830

Keywords:

Dental practitioners, herpetic neuritis, herpes zoster, lesions, shingles

Abstract

Herpetic neuritis is indeed a painful infection that damages both the nerve fibers as well as the skin. This is a shingles side effect. It is also the resurgence of varicella zoster virus, or chickenpox virus, that has been latent in the sensory root ganglia of the neural system from early life. The purpose of the survey was for determining the knowledge,awareness and management practices of herpetic neuritis in a dental clinical setup among dental practitioners. A total of 100 dental practitioners were randomly enrolled in the study and voluntarily completed a questionnaire consisting of 10 close – ended questions. Questionnaire consist of questions based on demographic characteristics, knowledge on risk factors , causes , signs and symptoms ,various diagnostic aids, management of herpetic neuritis etc.Questionnaire data was gathered by sharing survey planet link to the selected population. Data was entered in Microsoft excel sheets and statistically analysed . Around 99% of the dental practitioners are aware of symptoms of herpetic neuritis. Almost all the dental practitioners attended the survey are aware of the various risk factors of herpetic neuritis and its most important and common diagnostic factor.About 91.1% of the population are aware of the primary prevention of herpetic neuritisAbout 96% of the participants were aware about the various diagnostic aids and management practices of herpetic neuritis patients and implement them in their clinical practice.The knowledge and awareness among dentists about herpetic neuritis patients in a clinical setup is adequate and some of dentists had negative attitude towards the management practices..Organising seminars and additional classes about herpetic neuritis and its management protocol may help to gain more knowledge about the disease.

Downloads

Download data is not yet available.

References

1. Arani, R. B., Soong, S.-J., Weiss, H. L., Wood, M. J., Fiddian, P. A., Gnann, J. W., & Whitley, R. (2001). Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Statistics in Medicine, 20(16), 2429–2439. https://doi.org/10.1002/sim.851

2. Arvin, A. (2005). Aging, Immunity, and the Varicella–Zoster Virus. New England Journal of Medicine, 352(22), 2266–2267. https://doi.org/10.1056/nejmp058091

3. Chernev, I., & Dado, D. (2013). Segmental zoster abdominal paresis (zoster pseudohernia): a review of the literature. PM & R: The Journal of Injury, Function, and Rehabilitation, 5(9), 786–790.

4. Coen, P. G., Scott, F., Leedham-Green, M., Nia, T., Jamil, A., Johnson, R. W., & Breuer, J. (2006). Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice? European Journal of Pain, 10(8), 695–700.

5. Gauthier, A., Breuer, J., Carrington, D., Martin, M., & Rémy, V. (2009). Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiology and Infection, 137(1), 38–47.

6. Guenther, L. C. (2006). Herpes zoster and postherpetic neuralgia. Expert Review of Dermatology, 1(4), 607–618. https://doi.org/10.1586/17469872.1.4.607

7. Hempenstall, K., Nurmikko, T. J., Johnson, R. W., A’Hern, R. P., & Rice, A. S. C. (2005). Analgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic Review. PLoS Medicine, 2(7), e164. https://doi.org/10.1371/journal.pmed.0020164

8. Jeon, Y. H. (2015). Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment. The Korean Journal of Pain, 28(3), 177–184.

9. Johnson, R. W. (2010). Herpes zoster and postherpetic neuralgia. Expert Review of Vaccines, 9(sup3), 21–26. https://doi.org/10.1586/erv.10.30

10. Johnson, R. W., & Whitton, T. L. (2004). Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opinion on Pharmacotherapy, 5(3), 551–559. https://doi.org/10.1517/14656566.5.3.551

11. Jung, B. F., Johnson, R. W., Griffin, D. R. J., & Dworkin, R. H. (2004). Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology, 62(9), 1545–1551. https://doi.org/10.1212/01.wnl.0000123261.00004.29

12. Nalamachu, S., & Morley-Forster, P. (2012). Diagnosing and Managing Postherpetic Neuralgia. Drugs & Aging, 29(11), 863–869. https://doi.org/10.1007/s40266-012-0014-3

13. Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., Weinberg, A., Boardman, K. D., Williams, H. M., Zhang, H., Peduzzi, P. N., Beisel, C. E., Morrison, V. A., Guatelli, J. C., Brooks, P. A., … Silber, J. L. (2005). A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. New England Journal of Medicine, 352(22), 2271–2284. https://doi.org/10.1056/nejmoa051016

14. Sampathkumar, P., Drage, L. A., & Martin, D. P. (2009). Herpes Zoster (Shingles) and Postherpetic Neuralgia. Mayo Clinic Proceedings, 84(3), 274–280. https://doi.org/10.4065/84.3.274

15. Volpi, A., Gatti, A., Pica, F., Bellino, S., Marsella, L. T., & Sabato, A. F. (2008). Clinical and psychosocial correlates of post-herpetic neuralgia. Journal of Medical Virology, 80(9), 1646–1652.

Downloads

Published

03.12.2019

Issue

Vol. 23 No. 6 (2019): 23 (6) 2019

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

M, A., Ganapathy, D., & Rohinikumar, S. (2019). AWARENESS OF HERPETIC NEURITIS AMONG DENTAL PRACTITIONERS . International Journal of Psychosocial Rehabilitation, 23(6), 1028-1037. https://doi.org/10.61841/ychgh830